Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Imran Ashraf

Orthopaedic Surgery Hoboken, NJ Medical Doctor

NPI 1134446529 CMS profile 1389398

1320 Adams St Ste D&E, Hoboken, NJ 07030

Open in the dashboard

General payments

$3,754

58 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Imran Ashraf of Hoboken, NJ is reported in the CMS Open Payments database as having received $3,754 across 58 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 51st percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $64 2
2024 General $450 6
2023 General $892 13
2022 General $222 8
2021 General $347 6
2020 General $375 7
2019 General $1,404 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Imran Ashraf
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Imran Ashraf were reported at $64. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Imran Ashraf Orthopaedic Surgery median Middle half National median
2019 $1,404 $644 $140–$2,844 $163
2020 $375 $312 $75–$1,860 $114
2021 $347 $520 $117–$2,495 $132
2022 $222 $598 $128–$2,731 $149
2023 $892 $461 $128–$2,264 $160
2024 $450 $497 $134–$2,475 $164
2025 $64 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $1,832 24 payments
  2. DePuy Synthes Sales Inc. $728 11 payments
  3. Boston Scientific Corporation $407 4 payments
  4. Abbott Laboratories $231 2 payments
  5. Zimmer Biomet Holdings, Inc. $144 2 payments
  6. Nevro Corp. $84 1 payment
  7. Medtronic Vascular, Inc. $81 2 payments
  8. Intra-Sana Laboratories $64 2 payments
  9. Smith+Nephew, Inc. $36 2 payments
  10. Paratek Pharmaceuticals, Inc. $30 2 payments
  11. Other $118 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,883 54 payments
  2. Travel and Lodging $871 4 payments
Products named General payments · program years 2019–2025
  1. MAKO Knees, Hips $1,215 11 payments
  2. MAKO Knees, Hips $436 10 payments
  3. HEALIX KNOTLESS PEEK $278 2 payments
  4. FMS $244 2 payments
  5. RIGIDLOOP $242 2 payments
  6. TRIATHLON $167 1 payment
  7. ACCOLADE $167 1 payment
  8. GENERAL PAIN MANAGEMENT $167 2 payments
  9. DYNATAPE $150 1 payment
  10. CINCHLOCK $147 1 payment
  11. Other $1,535 34 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 29 billing codes

Paid by Medicare

$33,072

Of which drugs: $7,172

Medicare patients

69

Average age 73

Services billed

349

43 women, 26 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 36%
Ischemic heart disease 25%
Chronic kidney disease 19%
Depression 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose J7323 Office 21 79 $7,168

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

58 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record